faCellitate
company
About
faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.
- Mannheim,Baden-Wurttemberg,Germany
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- €3.70M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- faCellitate GmbH.
- Also Known As
- faCellitate - Combine Function with Your Labware
faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€3.70M
faCellitate has raised a total of
€3.70M
in funding over 2 rounds. Their latest funding was raised on
Sep 7, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 7, 2022 | Seed | €3.70M | 6 |
High-Tech Grunderfonds
SARSTEDT
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
6
faCellitate is funded by 6 investors.
High-Tech Grunderfonds
and SARSTEDT
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
High-Tech Grunderfonds
|
Yes | Seed |
|
SARSTEDT
|
Yes | Seed |
|
|
— | Seed |
Chemovator
|
— | Seed |
R3
|
— | Seed |
ROI land investment
|
— | Seed |
Employee Profiles
Number of Employee Profiles
1
faCellitate has 1 current employee profiles, including
Executive Simon Widmaier
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
